The value-added of chemical and pharmaceutical products in Germany exhibited steady growth from 2013 to 2023, increasing from 62.19 billion Euros to 75.77 billion Euros. Year-on-year variations highlight fluctuations, with notable increases in 2014 (5.33%) and 2016 (6.94%). However, there were slight declines in 2017 (-1.8%) and 2019 (-1.22%). The last two years saw moderate growth, with 2022 at 1.29% and 2023 at 1.25%. The 5-year CAGR leading to 2023 stood at 1.01%, indicating a stable but modest upward trend.
Forecast data from 2024 to 2028 suggests continued incremental growth, with the value-add expected to reach 80.17 billion Euros by 2028. This period is projected to have an average annual growth rate (CAGR) of 0.89%, reflecting a slight deceleration in growth pace. Key future trends to watch include potential impacts of regulatory changes, advancements in biotechnology, and shifts in global demand for pharmaceuticals and chemicals.
